The value of screening for sexually transmitted diseases in an HIV clinic.
about
Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infectionsTREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cellsImproving sexual health for HIV patients by providing a combination of integrated public health and hospital care services; a one-group pre- and post test intervention comparison.Screening for gonorrhea: recommendation statementPhosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathwaysGonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelinesModelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007.Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 ProfileBrief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States.Increasing HIV testing among latinos by bundling HIV testing with other tests.Counseling to reduce high-risk sexual behavior in HIV care: a multi-center, direct observation study.Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women.Prevalence of asymptomatic urethritis by Chlamydia trachomatis and Neisseria gonorrhoeae and associated risk factors among males living with HIV-1.Chlamydia trachomatis asymptomatic urethritis recurrence among males living with HIV-1
P2860
Q26991442-BE55B603-A2E3-4F57-AD41-6E0A9215B142Q28589939-28FCEB6D-29A5-42C2-A5F1-5746C6E556C6Q34523865-3304E8B9-2092-4483-BBC8-4D79C70CBF44Q34629225-5855D134-BC04-44F2-B9BD-E9B99D6C23B2Q34690369-6BE9A272-4EBB-4A4F-93C4-06C64B0501A7Q34731485-6E176EC9-5F22-4992-AB93-8E63F32B38E2Q34991890-98D2D03E-E8B6-4F62-8D36-FBA7763DEA59Q35216270-6EF76598-2D27-4E49-B657-A33E37E59A77Q35678733-B627003A-B014-46E6-98EE-EB3CF38D720FQ36166942-453D52E5-6B89-4A01-BE61-3BC24877D78CQ36735539-90F97363-82EB-48F9-8EFA-0F052D4BD016Q36991288-3D65638C-89B0-4A62-8715-2308934FDF2EQ37003224-AF3A72F4-54CE-4A8C-B69A-4D81EA57A3FEQ54256056-0B19D3DE-8F7F-4F69-94E9-5E23829DEE07Q58117383-5FD24C85-E39F-4067-A1A3-6666907762FB
P2860
The value of screening for sexually transmitted diseases in an HIV clinic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The value of screening for sexually transmitted diseases in an HIV clinic.
@en
The value of screening for sexually transmitted diseases in an HIV clinic.
@nl
type
label
The value of screening for sexually transmitted diseases in an HIV clinic.
@en
The value of screening for sexually transmitted diseases in an HIV clinic.
@nl
prefLabel
The value of screening for sexually transmitted diseases in an HIV clinic.
@en
The value of screening for sexually transmitted diseases in an HIV clinic.
@nl
P2093
P921
P1476
The value of screening for sexually transmitted diseases in an HIV clinic.
@en
P2093
Ceryl Lynn Besch
Deborah A Cohen
Shin-Yi Wu
Thomas A Farley
P304
P356
10.1097/00126334-200308150-00014
P407
P577
2003-08-01T00:00:00Z